UTHR United Therapeutics Corporation

NASDAQ
$559.10

United Therapeutics Corporation (UTHR) is expected to report earnings on February 3, 2027, before the market open. The consensus earnings estimate is $6.36 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.2% since its last earnings release on November 4, 2026.

United Therapeutics Missed Consensus Estimates
Wednesday, November 4, 2026 · 6:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 6:30 AM ET
Earnings Whisper
-
vs $6.36
Rev est $811.89M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $584.44

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About United Therapeutics Corporation

United Therapeutics Corp is a biotechnology company. The Company is engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.